Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Lipolysis Enhancement and Lipogenesis Inhibition In obese Zucker rats, daily oral administration of AOD9604 significantly increased lipolytic activity in adipose tissue compared to controls, establishing direct adipocyte-level lipolysis stimulation as a key mechanism of action in pre-clinical models
Im into week 3 and I can see the difference this is making
This treatment is typically recommended for adults with obesity or those who have a BMI of 27 or higher with related health conditions such as diabetes, high blood pressure, or high cholesterol, and can be a valuable tool for achieving long-term weight management when combined with a healthy lifestyle
The treatment starts with a big dose, then smaller doses are given regularly
